Brief: Egetis Therapeutics Appoints Yilmaz Mahshid As New CFO
April 19 (Reuters) - Egetis Therapeutics AB (publ)
EGTX.ST :
* EGETIS THERAPEUTICS APPOINTS YILMAZ MAHSHID AS NEW CFO
* YILMAZ MAHSHID, PHD, HAS BEEN APPOINTED CHIEF FINANCIAL
OFFICER
(CFO), JOINING IN Q2 OF 2021
* YILMAZ MAHSHID IS TAKING OVER FROM MARIE-LOUISE ALAMAA,
WHO
JOINED AS INTERIM CFO IN JUNE 2020.
Source text for Eikon: ID:nMFN9lvdcQ
Further company coverage: EGTX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Egetis Therapeutics AB (publ)
See all newsBrief: Egetis Announces Grant Of Patent For MCT8 Deficiency Composition In U.S.
Swedisg drugmaker Egetis's Q1 revenue rises 9% on Emcitate sales in Europe
Brief: Egetis Therapeutics Q1 Loss SEK 94.5 Mln
Brief: Egetis Plans Directed Share Issue Raising SEK 350 Million
Brief: Egetis Therapeutics Appoints Tiago Nunes As CMO Effective May 1